Immuneering
IMRX
IMRX
52 hedge funds and large institutions have $130M invested in Immuneering in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+3
Holders Change %
+6.12%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
24
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
TD Asset Management
Toronto,
Ontario, Canada
|
$2.18M |
| 2 |
2
BlackRock
New York
|
$19.3M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$3.32M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$8.02M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.77M |
